Posted on February 9, 2010.
Soy protein Soybeans were known to be very rich in protein and is considered an important factor in reducing cholesterol in our body. It reduces bad cholesterol risks referred to as Low Density Lipoprotein LDL and others to develop a heart problem. contains proteins and soy isoflavones study has shown it can improve arterial function in patients with stroke. Patients with cardiovascular disease can use supplements of isoflavones in soy protein to contribute to improving the way the brachial artery (the main artery of the arm) dilates in response to an increase blood flow of a phenomenon known as flow mediated dilation (FMD).
According to the research was conducted by a group of students from the University of Hong Kong, China, they came up with results that after a patient suffering from cardiovascular disease is administered isoflavoe surcharge, which in this where soy protein was twelve weeks at a dose of 80 mg per day, they have greatly improved. (Hung-Fat Tse, 2004). Brachial FMD is an indicator of how cells that usually line the inner surface of blood vessels and endothelial dysfunction is implicated in cardiovascular disease.
In the study, the trial was conducted involving thirty patients taking the isoflavone supplement and taking forty placebo pill. The researchers measured FMD by ultrasound to record the speed at which the brachial artery that carried the blood flowed.FMD was defined as the percentage change in brachial artery diameter between its normal size (from base) and one minute after deflation of the tourniquet. " After twelve weeks of isoflavone or placebo, results showed that eighty percent of patients had an impaired FMD of less than 3.7% showed an improvement of one percent of patients isoflavones compared with controls.
Eighty percent of patients had an impaired FMD of less than 3.7% at baseline, but after 12 weeks of isoflavone or placebo, there was a one percent improvement in patients treated by isoflavones compared with controls. Patients with lower initial FMD were found to respond with an absolute increase in FMD. The study has explained that the work of isoflavones in reversing endothelial dysfunction in this group of patients. This type of treatment is given to the group of patients who are at high risk of cardiovascular disease.
No improvement of isoflavone treatment was found in diabetic patients compared to patients without diabetes, but there was an improvement of one per cent among patients who were current smokers or had smoked in the past in relation non-smokers or never. This is because smoking is known to be associated with more severe endothelial dysfunction. The results clearly indicate that patients with worse endothelial function basis are more sensitive to treatment. (William, 2007)
Research has also shown that isoflavones help significantly decrese the sensitivity of elevated C-reactive protein. This increase in protein during inflammation is a systematic and independent predictor of cardiovascular events linked. The treatment relieves vascular inflammatory stress and is an important component that mediates the reversal of endothelial dysfunction.
Recent discoveries have shown that plasma cholesterol is not yet supported in recent publications. In some cases, it was reported that the vasodilatory effects of the microcirculation with isoflavones or their metabolites can provide opportunities for pharmacological intervention. In the past it has been suggested that power soya may be due to the high amounts of isoflavones, but later it was discovered that these natural compounds showed benefits for symptoms of menopause and the other conditions related hormone, research has concluded that isoflavones do not lower cholesterol.
Some minor reductions in LDL-cholesterol.
